
Not exactly a love letter to AmEx
Galvin Gaustad & Stein LLC trimmed its American Express position by 10.7%, leaving it with 58,382 shares worth about $21.6 million. That still makes AXP a chunky 1.7% of the firm’s portfolio, so this is more “lighten up a little” than “run for the exits.”
The insider tea is getting warmer
The article also notes that company insiders sold 73,944 shares last quarter for roughly $26.11 million. The headline sales included Denise Pickett and Anna Marrs, both unloading meaningful chunks in early February. That doesn’t automatically scream trouble, but when insiders are taking chips off the table, investors usually lean in and ask: what do they know that I don’t?
Dividends and price targets: the mixed message
AmEx did toss shareholders a little candy by raising its quarterly dividend to $0.95 a share, or $3.80 annualized. With an ex-dividend date of April 2 and payment due May 8, income investors got a small morale boost.
Meanwhile, the analyst crowd is still in “meh” territory. The article says the average rating is Hold, with a $351.20 target price, while recent calls ranged from Barclays cutting its target to Wells Fargo trimming its own and UBS staying neutral. So the message is pretty clear: Wall Street sees value, but not enough fireworks to start throwing confetti.
Big picture
For AmEx, this is the kind of news that doesn’t change the whole movie, but it does nudge the vibe. A dividend bump helps, yet insider selling plus cautious analyst targets can keep a lid on enthusiasm. If you own the stock, this is a good one to file under: fine company, cautious sentiment.
